IL-6 receptor inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IL-6 receptor inhibitor, covering 2013-04-19 to 2013-04-19. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent. [Phase 4]